Revenue
2022
2023
2024
2025
Advanced Medical Solutions Group plc (AMS)
Price£2.81Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | £228.9M | £177.5M | £126.2M | £124.3M |
| Operating expenses | £93.7M | £70.5M | £51.3M | £48.5M |
| Operating income | £28.5M | £22.1M | £18.9M | £24.9M |
| Operating margin | 12.43% | 12.47% | 14.96% | 20.02% |
| EBITDA | £44.0M | £29.5M | £32.3M | £35.1M |
| EBITDA margin | 19.21% | 16.63% | 25.62% | 28.25% |
| Net income | £10.1M | £7.1M | £15.9M | £20.4M |
| Net profit margin | 4.41% | 4.02% | 12.59% | 16.41% |
| Basic EPSper basic share | £0.05 | £0.03 | £0.07 | £0.09 |
| Diluted EPSper diluted share | £0.05 | £0.03 | £0.07 | £0.09 |
Owners
Reported major voting-rights holders
6.92%of voting rights
Octopus Investments LimitedNotified Sep 16, 2026
View holders
| Holder | Voting rights |
|---|---|
Octopus Investments Limited | 6.92%Sep 16, 2026 · 15.28M votes |
JPMorgan Chase & Co. | 4.32%Oct 9, 2026 · 9.5M votes |
Rathbones Investment Management Ltd | 3.86%Jul 16, 2026 · 8.52M votes |
Briarwood Chase Management LLC | 2.57%Jun 25, 2026 · 5.66M votes |
Morgan Stanley | <0.01%Aug 27, 2026 · 100 votes |
These are threshold-crossing notices, not a complete ownership register. Percentages show issuer voting rights held through the listed share class, exclude financial instruments, and come from different dates. Positions may overlap.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: FCA National Storage Mechanism ↗Updated Oct 21, 2026